FMP
Soliton, Inc.
SOLY
NASDAQ
Inactive Equity
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
22.58 USD
0 (0%)
About
ceo
Dr. Christopher C. Capelli
sector
Healthcare
industry
Medical - Devices
website
https://www.soliton.comexchange
NASDAQ
Description
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
CIK
0001548187
ISIN
US8342511008
CUSIP
834251100
Address
5304 Ashbrook Dr
Phone
18326613453
Country
US
Employee
13
IPO Date
Feb 19, 2019
Key Executives
